GenMark Diagnostics, Inc. announced that Scott Mendel, Chief Operating Officer, has been appointed Interim President and Chief Executive Officer effective February 10, 2020. Hany Massarany has stepped down as President and CEO and as a member of the company's Board of Directors, effective February 10, 2020. A search has commenced to identify a permanent CEO.

Concurrently Kevin O'Boyle has been appointed Chairman of the Board and James Fox, PhD., GenMark's prior Chairman, will remain on the Board as a non-executive director. Mendel has served as GenMark's Chief Operating Officer since February 2019. Previously, he served as Chief Financial Officer since joining the company in 2014.

Prior to joining GenMark, Mendel held various roles of increasing responsibility at The Active Network and GE Healthcare.